Complement-Regulatory Proteins CFHR1 and CFHR3 and Patient Response to Anti-CD20 Monoclonal Antibody Therapy
Laura M. Rogers(University of Iowa), George J. Weiner(University of Iowa), Sarah L. Mott(University of Iowa), Brian K. Link(University of Iowa), Deniz Şahin(Roche (Switzerland))
Cited by 32
Related Papers
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
|Proceedings of the National Academy of Sciences|2012|990
Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma
|Journal of Surgical Oncology|2014|274
Indications for and outcome of total abdominal hysterectomy for benign disease: a prospective cohort study
|BJOG An International Journal of Obstetrics & Gynaecology|1995|215
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia
|Nature Genetics|2013|211
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer
|The Journal of Urology|2019|190